Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.4 USD | +3.22% | -1.36% | +30.09% |
Sales 2024 * | 266M 22.19B | Sales 2025 * | 428M 35.65B | Capitalization | 4.62B 384B |
---|---|---|---|---|---|
Net income 2024 * | 62M 5.16B | Net income 2025 * | 160M 13.33B | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 594M 49.48B | Net cash position 2025 * | 799M 66.54B | EV / Sales 2025 * | 8.92 x |
P/E ratio 2024 * |
71.5
x | P/E ratio 2025 * |
29.4
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.24% |
Latest transcript on Krystal Biotech, Inc.
1 day | +3.22% | ||
1 week | -1.36% | ||
Current month | +5.40% | ||
1 month | +5.40% | ||
3 months | -3.83% | ||
6 months | +54.84% | ||
Current year | +30.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 15/16/15 | |
Suma M. Krishnan
FOU | Founder | 59 | 15/16/15 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 01/16/01 |
Suma M. Krishnan
FOU | Founder | 59 | 15/16/15 |
Dino Rossi
BRD | Director/Board Member | 69 | 01/17/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 161.6 | +3.36% | 198,886 |
29/24/29 | 156.4 | -1.67% | 154,069 |
28/24/28 | 159 | -2.35% | 238,150 |
24/24/24 | 162.8 | -0.48% | 144,963 |
23/24/23 | 163.6 | -3.33% | 302,773 |
Delayed Quote Nasdaq, May 31, 2024 at 01:29 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.09% | 4.62B | |
+8.92% | 114B | |
+10.48% | 105B | |
-1.83% | 21.73B | |
-6.45% | 23.83B | |
-10.39% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- KRYS Stock